Alnylam Pharmaceuticals, Inc. logo ALNY - Alnylam Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 39
HOLD 12
SELL 1
STRONG
SELL
0
| PRICE TARGET: $445.67 DETAILS
HIGH: $530.00
LOW: $351.00
MEDIAN: $445.50
CONSENSUS: $445.67
UPSIDE: 49.83%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002
Revenue
Revenue 3,713.9 2,248.2 1,828.3 1,037.4 844.3 492.9 219.8 74.9 89.9 47.2 41.1 50.6 47.2 66.7 82.8 100.0 100.5 96.2 50.9 26.9 5.7 4.3 0.2 0
Cost of Revenue 677.2 323.4 310.4 168.8 140.1 78.1 25.1 1.8 13.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 3,036.8 1,924.9 1,517.9 868.6 704.1 414.8 194.7 73.1 76.5 47.2 41.1 50.6 47.2 66.7 82.8 100.0 100.5 96.2 50.9 26.9 5.7 4.3 0.2 0
Operating Expenses
R&D Expenses 1,324.5 1,126.2 1,004.4 883.0 792.2 654.8 655.1 505.4 390.6 382.4 276.5 190.2 113.0 86.6 99.3 106.4 108.7 96.9 120.7 49.8 35.3 24.6 13.1 3.3
SG&A Expenses 1,210.7 975.5 795.6 770.7 620.6 588.4 479.0 382.4 199.4 89.4 60.6 44.5 27.2 44.6 38.3 37.7 39.9 27.1 23.4 16.6 13.9 11.9 7.5 0.9
Other Expenses 0 0 0 0 (2.0) 0 0 4.2 (3.0) 0 0.1 1.8 (0.0) 0.3 0 0 0 0 0 0 0 0 0 0
Operating Expenses 2,535.2 2,101.8 1,800.1 1,653.7 1,412.8 1,243.2 1,134.1 887.8 590 471.7 337.1 234.8 140.1 131.2 137.6 144.1 148.6 124.0 144.1 66.4 49.2 36.5 20.6 4.2
Operating Income
Operating Income 501.6 (176.9) (282.2) (785.1) (708.7) (828.4) (939.4) (814.7) (500.1) (424.6) (296.0) (405.0) (92.9) (129.5) (54.8) (44.1) (48.1) (27.8) (93.2) (39.5) (43.5) (32.3) (25.1) (4.2)
Interest Expense 252.6 141.9 121.2 156.0 143.0 84.5 0 0 0 0 0 0 0 0 0 0 0 0.9 1.1 0 0 0 0 0
Interest Income 111.5 122.0 95.6 24.8 1.6 11.8 33.4 29.3 12.2 8.3 5.9 2.6 1.1 1.0 1.2 2.3 5.4 14.4 15.4 0 0 0 0 0
Profitability
EBITDA 557.2 (178.8) (258.2) (926.6) (661.6) (736.3) (868.1) (754.2) (488.2) (409.5) (277.0) (172.3) (82.7) (51.7) (49.7) (38.1) (41.0) (18.9) (75.1) (35.7) (38.8) (29.5) (19.6) (4.2)
EBIT 501.6 (235.5) (312.3) (971.0) (709.1) (771.1) (885.3) (760.7) (500.1) (424.6) (296.0) (184.2) (92.9) (63.6) (57.6) (43.7) (47.0) (24.7) (79.1) (39.5) (43.5) (32.3) (20.4) (4.2)
Income Before Tax 323.2 (377.4) (433.5) (1,127.0) (852.1) (855.6) (885.3) (760.7) (490.9) (410.1) (290.1) (400.6) (91.9) (116.6) (57.6) (43.0) (47.0) (25.5) (80.2) (34.6) (42.9) (35.4) (29.7) 0
Income Tax Expense 9.4 (99.2) 6.7 4.2 0.7 2.7 0.9 0.8 0 0 0 (40.2) (2.7) (10.6) 0 0.5 0.6 0.7 5.2 0 0 0.4 (4.6) (0.1)
Net Income 313.7 (278.2) (440.2) (1,131.2) (852.8) (858.3) (886.1) (761.5) (490.9) (410.1) (290.1) (360.4) (89.2) (106.0) (57.6) (43.5) (47.6) (26.2) (85.5) (34.6) (42.9) (32.7) (25.0) (4.1)
Per Share Data
EPS (Basic) 2.39 -2.18 -3.52 -9.30 -7.20 -7.46 -8.11 -7.57 -5.42 -4.79 -3.45 -4.85 -1.45 -2.11 -1.36 -1.04 -1.14 -0.64 -2.21 -1.09 -1.96 -2.75 -26.56 -12.48
EPS (Diluted) 2.33 -2.18 -3.52 -9.30 -7.20 -7.46 -8.11 -7.57 -5.42 -4.79 -3.45 -4.85 -1.45 -2.11 -1.36 -1.04 -1.14 -0.64 -2.21 -1.09 -1.96 -2.75 -26.56 -12.48
Shares Outstanding 131.0 127.7 124.9 121.7 118.5 115.0 109.3 100.6 90.6 85.6 84.0 74.3 61.6 50.3 42.4 42.0 41.6 41.1 38.7 31.9 21.9 11.9 0.9 0.3
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2009 2008 2004 2003 2002
Current Assets
Cash & Cash Equivalents 1,657.2 966.4 812.7 866.4 820.0 496.6 547.2 420.1 645.4 193.6 137.5 191.8 20.3 23.2 15.5
Short-Term Investments 1,251.2 1,728.1 1,626.7 1,326.0 1,615.6 1,377.8 989.0 664.0 1,045.3 433.2 143.9 238.6 25.8 0 0
Net Receivables 777.6 405.3 327.8 238.0 198.6 602.4 43.0 18.8 34.0 23.3 6.0 4.2 1.2 0 0
Inventory 82.7 78.5 89.1 129.0 86.4 75.2 56.3 24.1 0 0 0 0 0 0 0
Other Current Assets 281.9 117.0 126.4 132.9 0 0 0 0 0 0 1.9 3.9 0 0.4 0.0
Total Current Assets 4,050.7 3,295.3 2,982.7 2,692.2 2,808.6 2,614.8 1,715.9 1,200.7 1,764.7 671.9 293.5 443.1 48.2 24.2 15.5
Non-Current Assets
Property, Plant & Equipment 708.1 693.9 725.8 738.6 733.6 706.5 646.4 320.7 181.9 114.6 18.3 19.2 11.7 4.8 0.5
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0.6 0.8 3.4 3.9 0
Long-Term Investments 0 0 0 0 0 0 14.8 44.8 13.9 324.8 160.3 83.9 0 0 0
Other Non-Current Assets 81.6 133.9 111.3 115.5 101.1 85.8 18.1 8.6 34.2 151.6 0 3.2 2.8 2.4 0.1
Total Non-Current Assets 915.7 944.7 847.2 854.1 834.7 792.3 679.3 374.1 230.0 590.9 187.9 111.6 17.9 11.0 0.6
Total Assets 4,966.3 4,240.0 3,829.9 3,546.4 3,643.3 3,407.1 2,395.1 1,574.8 1,994.7 1,262.8 481.4 554.7 66.1 35.2 16.1
Current Liabilities
Account Payables 115.7 88.4 55.5 98.1 73.4 52.0 49.9 59.7 28.4 54.5 12.5 2.6 0.9 1.5 0.7
Short-Term Debt 0 113.0 0 0 0 0 0 0 0 0 0 0 0.8 0.6 0
Deferred Revenue 4.8 55.5 102.8 42.1 149.5 127.2 77.8 3.5 41.7 33.5 82.8 79.9 1 0.3 0
Other Current Liabilities 477.3 214.4 177.2 171.0 130.7 110.7 68.3 40.9 35.8 15.3 0 1.6 0 0 0
Total Current Liabilities 1,466.3 1,186.3 967.8 767.9 695.7 585.3 352.6 179.5 144.3 131.7 110.7 99.5 6.6 3.8 2.7
Non-Current Liabilities
Long-Term Debt 1,007.8 2,359.0 1,020.8 1,016.9 675.7 191.3 0 30 30 150 0 0 6.4 1.3 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 1,477.9 398.1 1,630.7 1,464.6 1,250.0 1,096.1 9.3 62.9 11.0 11.5 2.8 3.0 7.0 56.7 18.1
Total Non-Current Liabilities 2,710.8 2,986.6 3,082.7 2,936.7 2,359.4 1,805.5 603.8 93.3 84.0 210.9 192.7 253.1 13.4 58.0 18.1
Total Liabilities 4,177.2 4,172.9 4,050.5 3,704.6 3,055.1 2,390.8 956.4 272.8 228.3 342.6 303.4 352.6 20.0 61.9 20.8
Stockholders' Equity
Common Stock 1.3 1.3 1.3 1.2 1.2 1.2 1.1 1.0 1.0 0.9 0.4 0.4 0.2 0 0
Retained Earnings (6,702.5) (7,287.7) (7,009.6) (6,569.3) (5,438.2) (4,585.4) (3,727.1) (2,841.0) (2,147.7) (1,656.8) (299.8) (252.2) (63.0) (29.5) (4.5)
Accumulated Other Comprehensive Income (20.1) (34.5) (23.4) (44.7) (33.3) (43.6) (36.5) (33.2) (34.4) (33.4) 0.7 1.2 (3.3) (4.6) (0.2)
Total Stockholders' Equity 789.2 67.1 (220.6) (158.2) 588.2 1,016.2 1,438.7 1,302.0 1,766.4 920.2 178.0 202.1 46.1 (26.7) (4.6)
Total Liabilities & Equity 4,966.3 4,240.0 3,829.9 3,546.4 3,643.3 3,407.1 2,395.1 1,574.8 1,994.7 1,262.8 481.4 554.7 66.1 35.2 16.1
Debt Metrics
Total Debt 1,278.4 2,743.4 1,305.4 1,320.2 997.6 521.2 303.8 30 30 150 0 0 7.2 1.9 0
Net Debt (378.9) 1,777.0 492.7 453.9 177.6 24.6 (243.4) (390.1) (615.4) (43.6) (137.5) (191.8) (13.1) (21.3) (15.5)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2005 2004 2003 2002
Operating Activities
Net Income 313.7 (278.2) (440.2) (1,131.2) (852.8) (858.3) (886.1) (761.5) (490.9) (410.1) (42.9) (32.7) (25.0) (4.1)
Depreciation & Amortization 55.7 56.7 97.0 85.5 89.7 74.4 54.4 6.4 13.4 15.1 3.1 2.4 0.8 0.0
Stock-Based Compensation 348.2 272.1 221.7 230.6 165.7 139.9 174.8 157.8 92.8 75.5 0 4.1 0 0
Change in Working Capital (444.8) (214.1) 10.8 (35.6) (162.8) (12.7) 402.4 45.1 (2.9) 17.2 16.8 3.5 2.9 2.6
Other Non-Cash Items 253.4 261.9 214.9 309.2 174.2 95.8 (12.6) (6.8) 2.9 1.5 6.6 7.2 8.5 0.2
Operating Cash Flow 524.1 (8.3) 104.2 (541.3) (641.7) (615.0) (278.4) (562.6) (382.8) (307.7) (16.5) (19.6) (12.8) (1.3)
Investing Activities
Capital Expenditure (58.7) (34.3) (62.2) (72.1) (76.4) (70.4) (140.2) (126.9) (104.2) (64.6) (1.9) (9.0) (3.1) (0.6)
Acquisitions 0 0 0 0 0 0 0 0 0 0 40.4 0 (0.1) 0
Purchases of Investments (1,364.9) (1,712.0) (1,823.5) (1,977.0) (1,656.1) (2,025.6) (2,075.9) (1,104.0) (903.5) (759.3) (70.9) (33.5) 0 0
Sales/Maturities of Investments 1,802.3 1,571.7 1,553.8 2,231.6 1,463.5 1,691.7 1,775.4 1,518.7 597.3 1,116.5 32.4 7.7 0 0
Other Investing Activities 57.6 57.8 (4.4) (13.2) (4.4) (31.2) 23 (14.8) 120 (150) (40.4) 0 0 0
Investing Cash Flow 436.3 (116.8) (336.4) 169.4 (273.3) (435.5) (417.7) 272.9 (290.4) 142.6 (40.4) (34.6) (3.2) (0.6)
Financing Activities
Net Debt Issuance (546.9) 0 0 254.0 500 200 (30) 0 (120) 150 0.2 5.3 (1.1) 0
Stock Repurchased 0 0 0 0 0 0 0 (3.5) (0.3) (0.6) 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (8.3) (8.8) 24.7 (87.6) 500.9 695.5 71.3 0 83.9 14.1 0 0.3 (2.7) (0.0)
Financing Cash Flow (305.2) 294.2 172.1 425.8 1,247.1 995.0 823.2 65.5 1,124.9 177.8 52.6 51.0 23.7 17.3
Cash Position
Net Change in Cash 690.2 153.8 (53.7) 46.4 323.1 (50.6) 127.0 (224.2) 451.7 12.7 (4.5) (2.9) 7.7 17.3
Cash at Beginning 968.7 814.9 868.6 822.2 499.0 549.6 422.6 646.8 193.6 180.9 20.3 23.2 15.5 (1.8)
Cash at End 1,658.8 968.7 814.9 868.6 822.2 499.0 549.6 422.6 645.4 193.6 15.8 20.3 23.2 15.5
Free Cash Flow 465.4 (42.6) 41.9 (613.3) (718.1) (685.3) (418.6) (689.5) (487.0) (372.3) (18.4) (28.6) (15.9) (1.8)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002
Income Statement
Revenue 3,713.9 2,248.2 1,828.3 1,037.4 844.3 492.9 219.8 74.9 89.9 47.2 41.1 50.6 47.2 66.7 82.8 100.0 100.5 96.2 50.9 26.9 5.7 4.3 0.2 0
Gross Profit 3,036.8 1,924.9 1,517.9 868.6 704.1 414.8 194.7 73.1 76.5 47.2 41.1 50.6 47.2 66.7 82.8 100.0 100.5 96.2 50.9 26.9 5.7 4.3 0.2 0
Operating Income 501.6 (176.9) (282.2) (785.1) (708.7) (828.4) (939.4) (814.7) (500.1) (424.6) (296.0) (405.0) (92.9) (129.5) (54.8) (44.1) (48.1) (27.8) (93.2) (39.5) (43.5) (32.3) (25.1) (4.2)
Net Income 313.7 (278.2) (440.2) (1,131.2) (852.8) (858.3) (886.1) (761.5) (490.9) (410.1) (290.1) (360.4) (89.2) (106.0) (57.6) (43.5) (47.6) (26.2) (85.5) (34.6) (42.9) (32.7) (25.0) (4.1)
EPS (Diluted) 2.33 -2.18 -3.52 -9.30 -7.20 -7.46 -8.11 -7.57 -5.42 -4.79 -3.45 -4.85 -1.45 -2.11 -1.36 -1.04 -1.14 -0.64 -2.21 -1.09 -1.96 -2.75 -26.56 -12.48
Balance Sheet
Cash & Equivalents 1,657.2 966.4 812.7 866.4 820.0 496.6 547.2 420.1 645.4 193.6 137.5 191.8 20.3 23.2 15.5
Total Assets 4,966.3 4,240.0 3,829.9 3,546.4 3,643.3 3,407.1 2,395.1 1,574.8 1,994.7 1,262.8 481.4 554.7 66.1 35.2 16.1
Total Debt 1,278.4 2,743.4 1,305.4 1,320.2 997.6 521.2 303.8 30 30 150 0 0 7.2 1.9 0
Stockholders' Equity 789.2 67.1 (220.6) (158.2) 588.2 1,016.2 1,438.7 1,302.0 1,766.4 920.2 178.0 202.1 46.1 (26.7) (4.6)
Cash Flow
Operating Cash Flow 524.1 (8.3) 104.2 (541.3) (641.7) (615.0) (278.4) (562.6) (382.8) (307.7) (16.5) (19.6) (12.8) (1.3)
Capital Expenditure (58.7) (34.3) (62.2) (72.1) (76.4) (70.4) (140.2) (126.9) (104.2) (64.6) (1.9) (9.0) (3.1) (0.6)
Free Cash Flow 465.4 (42.6) 41.9 (613.3) (718.1) (685.3) (418.6) (689.5) (487.0) (372.3) (18.4) (28.6) (15.9) (1.8)